Search Results - "DE BOER, S. Y"

Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis by de Boer, Y. S., van Gerven, N. M. F., de Boer, N. K. H., Mulder, C. J. J., Bouma, G., van Nieuwkerk, C. M. J.

“…Summary Background Ten percent of patients with autoimmune hepatitis (AIH) are nonresponsive or intolerant to thiopurine therapy. A skewed metabolism, leading…”
Get full text

HLA-DRB103:01 and HLA-DRB104:01 modify the presentation and outcome in autoimmune hepatitis type-1 by van Gerven, N M F, de Boer, Y S, Zwiers, A, Verwer, B J, Drenth, J P H, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M M J, Vrolijk, J M, Coenraad, M J, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J, Bloemena, E, Verspaget, H W, Kumar, V, Zhernakova, A, Wijmenga, C, Franke, L, Bouma, G

“…The classical human leukocyte antigen (HLA)-DRB1*03:01 and HLA-DRB1*04:01 alleles are established autoimmune hepatitis (AIH) risk alleles. To study the…”
Get full text

Four‐day quadruple therapy as a routine treatment for Helicobacter pylori infection by BOER, S. Y. DE, SIEM, T. H.

“…Background: H. pylori eradication usually involves treatment with three or four drugs for at least 7 days. Possible advantages of short treatment regimens are…”
Get full text

Expert clinical management of autoimmune hepatitis in the real world by Liberal, R., Boer, Y. S., Andrade, R. J., Bouma, G., Dalekos, G. N., Floreani, A., Gleeson, D., Hirschfield, G. M., Invernizzi, P., Lenzi, M., Lohse, A. W., Macedo, G., Milkiewicz, P., Terziroli, B., Hoek, B., Vierling, J. M., Heneghan, M. A., Pares, A., Montano‐Loza, A. J., Granito, A., Kremer, A. E., Floreani, A., Lohse, A. W., Hoek, B., Terziroli, B., Schramm, C., Lammert, C., Cancado, E. L. R., Bjornsson, E., Lammert, F., Dalekos, G. N., Bouma, G., Hirschflield, G. M., Macedo, G., Hofer, H., Mackay, I., Neuberger, J., Vierling, J. M., Drenth, J.P.H., Nieuwkerk, C.M.J., Muratori, L., Lenzi, M., Swain, M., Heneghan, M., Zeniya, M., Chazouilleres, O., Gines, P., Invernizzi, P., Milkiewicz, P., Andrade, R. J., Chapman, R., Berg, T., Buuren, H., Ma, X.

“…Summary Background High‐quality data on the management of autoimmune hepatitis (AIH) are scarce. Despite published guidelines, management of AIH is still…”
Get full text

Letter: tacrolimus may be hazardous in decompensated autoimmune liver disease with hyperbilirubinemia—authors’ reply by Boer, Y. S., Liberal, R., Heneghan, M. A.

“…Linked Content This article is linked to Liberal et al and Shen et al papers. To view these articles visit https://doi.org/10.1111/apt.13907 and…”
Get full text

MAdCAM-1 does not play a central role in the early pathophysiology of autoimmune hepatitis by van den Brand, F.F., Masrati, H., Jordanova, E.S., Bloemena, E., Lissenberg-Witte, B.I., de Boer, Y.S., Bontkes, H.J., Mebius, R., Bouma, G.

“…[Display omitted] CD4+ T cells are thought to have a central role in the pathogenesis of autoimmune hepatitis (AIH). Mucosal addressin cell adhesion molecule-1…”
Get full text

Real-world management of juvenile autoimmune liver disease by de Boer, Y S, Liberal, R, Vergani, D, Mieli-Vergani, G

“…Background and aims Juvenile autoimmune liver disease (JAILD) includes paediatric forms of autoimmune hepatitis (AIH) and autoimmune sclerosing cholangitis…”
Get full text

Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection by DE BOER, S. Y, MEEBERG, P. C. V. D, SIEM, H, DE BOER, W. A

“…H. pylori eradication is usually performed with three or four drugs for at least seven days. Recently four reports have shown a cure rate of approximately 90%…”
Get full text

A Case of Autoimmune Hepatitis and Bisphosphonate-Related Osteonecrosis of the Jaw by de Boer, Y.S., Bouma, G., Wattjes, M.P., Lips, P., Mulder, C.J.J., van Nieuwkerk, C.M.J.

“…Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease of unknown aetiology usually requiring long-term immunosuppressive therapy. We present the…”
Get full text

Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission by DE JONG, D. J, BAC, D. J, TAN, G, DE BOER, S. Y, GRABOWSKY, I. L. F, JANSEN, J. B. M. J, GREINWALD, R, NABER, T. H. J

“…In previous trials, budesonide 6 mg/day was able to prolong the time to relapse in patients with quiescent Crohn's disease and budesonide 9 mg/day was…”
Get full text

Recurrent staphylococcal bacteraemia and subhepatic abscess associated with gallstones spilled during laparoscopic cholecystectomy two years earlier by VAN MIERLO, P. J. W. B, DE BOER, S. Y, VAN DISSEL, J. T, AREND, S. M

“…This is the first report of Staphylococcus aureus bacteraemia and subhepatic abscess in association with intraperitoneal gallstones spilled during laparoscopic…”
Get full text

Helicobacter pylori antibiotic resistance in a Dutch region : trends over time by JANSSEN, M. J. R, HENDRIKSE, L, DE BOER, S. Y, BOSBOOM, R, DE BOER, W. A, LAHEIJ, R. J. F, JANSEN, J. B. M. J

“…Most patients treated for H. pylori infection receive empirical therapy based on epidemiological data of antibiotic resistance. However, previous European…”
Get full text

Hyperglycaemia reduces gastrin-stimulated gastric acid secretion in humans by LAM, W. F, MASCLEE, A. A. M, DE BOER, S. Y, LAMERS, C. B. H. W

“…Background Recent studies have pointed to the role of plasma glucose in the regulation of gastrointestinal function. Methods We have investigated the effect of…”
Get full text

Letter: allopurinol co‐therapy is safe and effective in autoimmune hepatitis – authors' reply by Boer, Y. S., Gerven, N. M. F., Boer, N. K. H., Mulder, C. J. J., Bouma, G., Nieuwkerk, C. M. J.

Get full text

Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus by DE BOER, S. Y, MASCLEE, A. A. M, LAM, W. F, LEMKES, H. H. P. J, SCHIPPER, J, FRÖHLICH, M, JANSEN, J. B. M. J, LAMERS, C. B. H. W

“…Patients with diabetes mellitus are at increased risk of developing gallstones. This has been attributed, among other factors, to alterations in gallbladder…”
Get full text

Hyperglycemia modulates gallbladder motility and small intestinal transit time in man by DE BOER, S. Y, MASCLEE, A. A. M, SCHIPPER, W. F. L. J, JANSEN, J. B. M. J, LAMERS, C. B. H. W

Get full text

Effect of acute hyperglycaemia on gall bladder contraction induced by cholecystokinin in humans by de Boer, S Y, Masclee, A A, Jebbink, M C, Schipper, J, Lemkes, H H, Jansen, J B, Lamers, C B

“…This study examined the effect of acute hyperglycaemia, induced by intravenous glucose, on gall bladder motility. Six healthy volunteers were studied in random…”
Get full text

Influence of Hyperglycemia on the Satiating Effect of CCK in Humans by Lam, Wai F., Gielkens, Hugo A.J., De Boer, Sybrand Y., Lamers, Cornelis B.H.W., Masclee, AD A.M.

“…In the present study the effects of intraduodenal (i.d.) fat (endogenous CCK) and of CCK infusion on satiety were studied during normo- and hyperglycemic…”
Get full text

Hyperglycemia reduces gastric secretory and plasma pancreatic polypeptide responses to modified sham feeding in humans by Lam, W F, Masclee, A A, de Boer, S Y, Lamers, C B

“…We have investigated the effect of acute stable hyperglycemia on gastric acid secretion and serum gastrin and pancreatic polypeptide (PP) release. Gastric acid…”
Get more information

Effect of intravenous glucose on intravenous amino acid-induced gallbladder contraction and CCK secretion by DE BOER, S. Y, MASCLEE, A. A. M, LAM, W. F, JANSEN, J. B. M. J, LAMERS, C. B. H. W

“…The present study was undertaken to investigate the effect of acute hyperglycemia on the gallbladder contraction induced by intravenous administration of high…”
Get full text